Cited by 64

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster

Tsakiri, Eleni N., Iliaki, Kalliopi K., Höhn, Annika, Grimm, Stefanie, Papassideri, Issidora S., Grune, Tilman, Trougakos, Ioannis P.·2013·Free Radical Biology and Medicine

Abstract

Advanced glycation end product (AGE)-modified proteins are formed by the nonenzymatic glycation of free amino groups of proteins and, along with lipofuscin (a highly oxidized aggregate of covalently cross-linked proteins, sugars, and lipids), have been found to accumulate during aging and in several age-related diseases. As the in vivo effects of diet-derived AGEs or lipofuscin remain elusive, we sought to study the impact of oral administration of glucose-, fructose-, or ribose-modified albumin or of artificial lipofuscin in a genetically tractable model organism. We report herein that continuous feeding of young Drosophila flies with culture medium enriched in AGEs or in lipofuscin resulted in reduced locomotor performance and in accelerated rates of AGE-modified proteins and carbonylated proteins accumulation in the somatic tissues and hemolymph of flies, as well as in a significant reduction of flies health span and life span. These phenotypic effects were accompanied by reduced proteasome peptidase activities in both the hemolymph and the somatic tissues of flies and higher levels of oxidative stress; furthermore, oral administration of AGEs or lipofuscin in flies triggered an upregulation of the lysosomal cathepsin B, L activities. Finally, RNAi-mediated cathepsin D knockdown reduced flies longevity and significantly augmented the deleterious effects of AGEs and lipofuscin, indicating that lysosomal cathepsins reduce the toxicity of diet-derived AGEs or lipofuscin. Our…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.freeradbiomed.2013.08.186

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 63

  1. Ulrich, 2001, Protein glycation, diabetes, and aging, Recent Prog. Horm. Res., 56, 1, 10.1210/rp.56.1.1 · DOI
  2. Takeuchi, 2009, Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease, J. Alzheimers Dis., 16, 845, 10.3233/JAD-2009-0974 · DOI
  3. Nedić, 2013, Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology, Free Radic. Res., 47, 28, 10.3109/10715762.2013.806798 · DOI · Paper page
  4. Uribarri, 2005, Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects, Ann. N. Y. Acad. Sci., 1043, 461, 10.1196/annals.1333.052 · DOI
  5. Jung, 2007, Lipofuscin: formation, distribution, and metabolic consequences, Ann. N. Y. Acad. Sci., 1119, 97, 10.1196/annals.1404.008 · DOI · Paper page
  6. Marzabadi, 1991, Mechanisms of lipofuscinogenesis: effect of the inhibition of lysosomal proteinases and lipases under varying concentrations of ambient oxygen in cultured rat neonatal myocardial cells, APMIS, 99, 416, 10.1111/j.1699-0463.1991.tb05170.x · DOI
  7. Yin, 1996, Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores, Free Radic. Biol. Med., 21, 871, 10.1016/0891-5849(96)00175-X · DOI
  8. Sitte, 2000, Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts, FASEB J., 14, 1490, 10.1096/fj.99-0843com · DOI
  9. Terman, 2006, Mitochondrial damage and intralysosomal degradation in cellular aging, Mol. Aspects Med., 27, 471, 10.1016/j.mam.2006.08.006 · DOI
  10. Kirkwood, 2000, Why do we age?, Nature, 408, 233, 10.1038/35041682 · DOI · Paper page
  11. Rattan, 2006, Theories of biological aging: genes, proteins, and free radicals, Free Radic. Res., 40, 1230, 10.1080/10715760600911303 · DOI
  12. Wensink, 2013, Age-specificity and the evolution of senescence: a discussion, Biogerontology, 14, 99, 10.1007/s10522-012-9410-7 · DOI
  13. Rattan, 2008, Increased molecular damage and heterogeneity as the basis of aging, Biol. Chem., 389, 267, 10.1515/BC.2008.030 · DOI
  14. Trougakos, 2013, Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis, J. Proteomics, 10.1016/j.jprot.2013.02.024 · DOI
  15. Hubbard, 2012, Selective autophagy in the maintenance of cellular homeostasis in aging organisms, Biogerontology, 13, 21, 10.1007/s10522-011-9331-x · DOI
  16. Chondrogianni, 2012, Protein damage, repair and proteolysis, Mol. Aspects Med.
  17. Navon, 2009, The 26S proteasome: from basic mechanisms to drug targeting, J. Biol. Chem., 284, 33713, 10.1074/jbc.R109.018481 · DOI
  18. Baraibar, 2012, Changes of the proteasomal system during the aging process, Prog. Mol. Biol. Transl. Sci., 109, 249, 10.1016/B978-0-12-397863-9.00007-9 · DOI
  19. Pickering, 2012, Degradation of damaged proteins: the main function of the 20S proteasome, Prog. Mol. Biol. Transl. Sci., 109, 227, 10.1016/B978-0-12-397863-9.00006-7 · DOI
  20. Kastle, 2011, Protein oxidative modification in the aging organism and the role of the ubiquitin proteasomal system, Curr. Pharm. Des., 17, 4007, 10.2174/138161211798764898 · DOI
  21. Česen, 2012, Lysosomal pathways to cell death and their therapeutic applications, Exp. Cell Res., 318, 1245, 10.1016/j.yexcr.2012.03.005 · DOI
  22. Jacobson, 2010, Biomarkers of aging in Drosophila, Aging Cell, 9, 466, 10.1111/j.1474-9726.2010.00573.x · DOI
  23. Cai, 2007, Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression, Am. J. Pathol., 170, 1893, 10.2353/ajpath.2007.061281 · DOI
  24. Cai, 2008, Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan, Am. J. Pathol., 173, 327, 10.2353/ajpath.2008.080152 · DOI
  25. Cai, 2012, Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1, Proc. Natl. Acad. Sci. USA, 109, 15888, 10.1073/pnas.1205847109 · DOI
  26. Grimm, 2012, Cathepsins D and L reduce the toxicity of advanced glycation end products, Free Radic. Biol. Med., 52, 1011, 10.1016/j.freeradbiomed.2011.12.021 · DOI
  27. Höhn, 2010, Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells, Free Radic. Biol. Med., 48, 1100, 10.1016/j.freeradbiomed.2010.01.030 · DOI
  28. Höhn, 2011, Lipofuscin inhibits the proteasome by binding to surface motifs, Free Radic. Biol. Med., 50, 585, 10.1016/j.freeradbiomed.2010.12.011 · DOI
  29. Kim, 2007, Common aging pathways in worms, flies, mice and humans, J. Exp. Biol., 210, 1607, 10.1242/jeb.004887 · DOI
  30. Stolzing, 2006, Degradation of glycated bovine serum albumin in microglial cells, Free Radic. Biol. Med., 40, 1017, 10.1016/j.freeradbiomed.2005.10.061 · DOI
  31. Tsakiri, 2013, Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress, FASEB J., 27, 2407, 10.1096/fj.12-221408 · DOI
  32. Vernace, 2007, Aging perturbs 26S proteasome assembly in Drosophila melanogaster, FASEB J., 21, 2672, 10.1096/fj.06-6751com · DOI
  33. Trougakos, 1999, Biochemical and immunocytochemical analysis of vitellogenesis in the olive fruit fly Dacus (bactrocera) oleae (Diptera: Tephritidae), Cell Biol. Int., 23, 417, 10.1006/cbir.1999.0380 · DOI
  34. Tsakiri, 2013, Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging, Aging Cell, 12, 802, 10.1111/acel.12111 · DOI
  35. Grimm, 2010, Cathepsin D is one of the major enzymes involved in intracellular degradation of AGE-modified proteins, Free Radic. Res., 44, 1013, 10.3109/10715762.2010.495127 · DOI
  36. Uribarri, 2010, Advanced glycation end products in foods and a practical guide to their reduction in the diet, J. Am. Diet. Assoc., 110, 911, 10.1016/j.jada.2010.03.018 · DOI · Paper page
  37. Sitte, 2001, Lipofuscin accumulation in proliferating fibroblasts in vitro: an indicator of oxidative stress, Exp. Gerontol., 36, 475, 10.1016/S0531-5565(00)00253-9 · DOI
  38. Höhn, 2012, Lipofuscin is formed independently of macroautophagy and lysosomal activity in stress-induced prematurely senescent human fibroblasts, Free Radic. Biol. Med., 53, 1760, 10.1016/j.freeradbiomed.2012.08.591 · DOI
  39. Grune, 2004, Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging, and disease, Int. J. Biochem. Cell Biol., 36, 2519, 10.1016/j.biocel.2004.04.020 · DOI
  40. Queisser, 2010, Hyperglycemia impairs proteasome function by methylglyoxal, Diabetes, 59, 670, 10.2337/db08-1565 · DOI
  41. Cervantes-Laurean, 2005, Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment, Free Radic. Biol. Med., 38, 786, 10.1016/j.freeradbiomed.2004.11.030 · DOI
  42. Schmid, 2008, Induction of heat shock proteins and the proteasome system by casein-N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)lysine in Caco-2 cells, Ann. N. Y. Acad. Sci., 1126, 257, 10.1196/annals.1433.062 · DOI
  43. Yamagishi, 2002, Advanced glycation end products induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes, Biochem. Biophys. Res. Commun., 290, 973, 10.1006/bbrc.2001.6312 · DOI
  44. Bansal, 2012, Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro, Mol. Cell. Biochem., 361, 289, 10.1007/s11010-011-1114-9 · DOI
  45. Wautier, 2001, Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE, Am. J. Physiol. Endocrinol. Metab., 280, E685, 10.1152/ajpendo.2001.280.5.E685 · DOI
  46. Coughlan, 2009, RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes, J. Am. Soc. Nephrol., 20, 742, 10.1681/ASN.2008050514 · DOI
  47. Uribarri, 2007, Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects, Diabetes Care, 30, 2579, 10.2337/dc07-0320 · DOI
  48. Patel, 2012, Effect of dietary advanced glycation end products on mouse liver, PLoS One, 7, e35143, 10.1371/journal.pone.0035143 · DOI
  49. Wei, 2012, D-Ribose in glycation and protein aggregation, Biochim. Biophys. Acta, 1820, 488, 10.1016/j.bbagen.2012.01.005 · DOI
  50. Han, 2011, D-Ribose induces cellular protein glycation and impairs mouse spatial cognition, PLoS One, 6, e24623, 10.1371/journal.pone.0024623 · DOI
  51. Akhter, 2013, Moinuddin; Ahmad, S. Bio-physical characterization of ribose induced glycation: a mechanistic study on DNA perturbations, Int. J. Biol. Macromol., 58, 206, 10.1016/j.ijbiomac.2013.03.036 · DOI
  52. Chen, 2010, Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products, PLoS One, 5, e9052, 10.1371/journal.pone.0009052 · DOI
  53. Futerman, 2004, The cell biology of lysosomal storage disorders, Nat. Rev. Mol. Cell Biol., 5, 554, 10.1038/nrm1423 · DOI
  54. Pallauf, 2013, Autophagy, polyphenols and healthy ageing, Ageing Res. Rev., 12, 237, 10.1016/j.arr.2012.03.008 · DOI
  55. Hu, 2012, ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells, Int. J. Mol. Med., 29, 613, 10.3892/ijmm.2012.891 · DOI
  56. Shacka, 2007, Cathepsin D deficiency induces persistent neurodegeneration in the absence of Bax-dependent apoptosis, J. Neurosci., 27, 2081, 10.1523/JNEUROSCI.5577-06.2007 · DOI
  57. Khurana, 2010, Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo, PLoS Genet., 6, e1001026, 10.1371/journal.pgen.1001026 · DOI
  58. Myllykangas, 2005, Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses, Neurobiol. Dis., 19, 194, 10.1016/j.nbd.2004.12.019 · DOI
  59. Lamore, 2010, Proteomic identification of cathepsin B and nucleophosmin as novel UVA-targets in human skin fibroblasts, Photochem. Photobiol., 86, 1307, 10.1111/j.1751-1097.2010.00818.x · DOI
  60. Miura, 2010, Translocation of lysosomal cathepsin D caused by oxidative stress or proteasome inhibition in primary cultured neurons and astrocytes, Biol. Pharm. Bull., 33, 22, 10.1248/bpb.33.22 · DOI
  61. Semba, 2009, Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults, J. Am. Geriatr. Soc., 57, 1874, 10.1111/j.1532-5415.2009.02438.x · DOI
  62. Lin, 2003, Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice, Atherosclerosis, 168, 213, 10.1016/S0021-9150(03)00050-9 · DOI
  63. Zheng, 2002, Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products, Diabetes Metab. Res. Rev, 18, 224, 10.1002/dmrr.283 · DOI

Cited by

Sorted by citations

See all 64

Metadata

Authors
Tsakiri, E. N., Iliaki, K. K., Höhn, A., Grimm, S., Papassideri, I. S., Grune, T., & Trougakos, I. P.
Venue
Free Radical Biology and Medicine
Publisher
Elsevier BV
Published
2013-12
Volume
65
Pages
1155-1163
ISSN
0891-5849
Cited by
64
References
3
Language
en
Funders
EU-FP7 Capacities (REGPOT-CT-2011-284460)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster. https://app.cochat.ai/papers/10.1016/j.freeradbiomed.2013.08.186
The paper
Tsakiri, E. N., Iliaki, K. K., Höhn, A., Grimm, S., Papassideri, I. S., Grune, T., & Trougakos, I. P. (2013). Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster. Free Radical Biology and Medicine. https://doi.org/10.1016/j.freeradbiomed.2013.08.186